Novavax enters deal with New Zealand for 10.7M doses of COVID-19 vaccine candidate
Dec 17 (Reuters) – Biotechnology company Novavax Inc said it had entered an agreement with the government of New Zealand for 10.7 million doses of its COVID-19 vaccine candidate. “Under […]